US Stock MarketDetailed Quotes

GDTC CytoMed Therapeutics

Watchlist
  • 2.380
  • -0.010-0.42%
Close Jan 17 16:00 ET
  • 2.350
  • -0.030-1.26%
Post 20:01 ET
27.47MMarket Cap-12.27P/E (TTM)

CytoMed Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CytoMed Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 8, 20242024/Q2-- / 156.000K--
--2024/Q1-- / 156.000K--
--2023/Q4-- / 130.000K--
--2023/Q3-- / 130.000K--
Nov 22, 20232023/Q2-- / 130.000K--
DatePeriodRevenue/EstimateEarnings Call
Oct 8, 20242024/Q2-- / 156.000K--
--2024/Q1-- / 156.000K--
--2023/Q4-- / 130.000K--
--2023/Q3-- / 130.000K--
Nov 22, 20232023/Q2-- / 130.000K--

Unlock Free Earnings Estimates

CytoMed Therapeutics Earnings Reports

  • CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 30, 2024 07:03 ET

  • CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    May 24, 2024 11:16 ET

  • CytoMed Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)

    Apr 25, 2024 15:36 ET

  • CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 24, 2024 16:19 ET

    • Read more

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data